Fig. 1: Survival of 604 patients with primary myelofibrosis and normal karyotype

Survival in 604 patients with primary myelofibrosis and normal karyotype, stratified by number of metaphases evaluated and the presence of single-metaphase abnormalities classically associated with myeloid disorders that do not qualify as being “clonal” per ISCN criteria